Adjuvant therapy in stage II colon cancer: current approaches.
about
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patientsMicrosatellite instability in colorectal cancer-the stable evidence.Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.The impact of age on quality measure adherence in colon cancer.Adjuvant therapies for colorectal cancer.What is the optimal means of staging colon cancer?FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.The role of molecular markers in predicting response to therapy in patients with colorectal cancer.Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer.Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer.Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
P2860
Q24569637-5867359D-9269-4A8F-9F7A-C982926DE205Q34616565-9D283532-9DC5-4555-82B6-BF28C1EDD8D8Q35580945-E73E5570-51AE-4B24-95A5-F8C27D638922Q35584153-34248210-F7E2-4A18-AABD-B8B9EF4DE991Q35792920-A9E6FE2D-5B47-40CD-860C-708C707599E8Q36177963-FC5918DF-2B18-46E9-A025-5FC1DC0A483DQ36315152-24F5A77E-2BE7-414B-8D8C-59B4980CF843Q37040688-80499B5D-DCBC-449D-811E-6DD8C239FD72Q37142001-FBDA3263-4828-4482-BD36-053A00FE9EC2Q38621235-23D01FE5-50AD-4803-BA83-F9B817A94369Q38827252-D3FEA7D0-5268-41D5-9BC5-75F03F9E2074Q38922299-15F30C7B-6CF2-4B76-A6D5-6E096A4F5837Q39907463-0443C8AE-0AFC-426D-BFE2-59C8C72EB262Q42954285-71906D9D-934A-41A0-9E55-B606E984CFEFQ43657921-4C168E53-A219-4CDB-9B12-902238E053AEQ44542942-58E6C8B6-3BB7-477F-8716-54AF08030647
P2860
Adjuvant therapy in stage II colon cancer: current approaches.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Adjuvant therapy in stage II colon cancer: current approaches.
@ast
Adjuvant therapy in stage II colon cancer: current approaches.
@en
type
label
Adjuvant therapy in stage II colon cancer: current approaches.
@ast
Adjuvant therapy in stage II colon cancer: current approaches.
@en
prefLabel
Adjuvant therapy in stage II colon cancer: current approaches.
@ast
Adjuvant therapy in stage II colon cancer: current approaches.
@en
P1433
P1476
Adjuvant therapy in stage II colon cancer: current approaches.
@en
P2093
P304
P356
10.1634/THEONCOLOGIST.10-5-325
P577
2005-05-01T00:00:00Z